5/6, 5:13 PM (Source: TeleTrader)
more TeleTrader news

BioNTech: Patent waiver won't aid vaccine production

German firm BioNTech said on Thursday that waiving patent protections for coronavirus vaccines won't increase production of the jabs in the short and middle term.

"Patents are not the limiting factor for the production or supply of our vaccine. They would not increase the global production and supply of vaccine doses in the short and middle term," BioNTech told AFP in a statement following news that the United States supports waiving intellectual property protections for COVID-19 vaccines in order to ramp up global production amid the pandemic.

In partnership with Pfizer, BioNTech developed the first coronavirus vaccine to be approved for emergency use in the US and the European Union.

Breaking the News / JC